TORONTO, May 7 /CNW/ - DELISTING REVIEW - Response Biomedical Corp. (the
"Company") - Further to TSX Bulletin 2008-1528 dated December 24, 2008, TSX
has extended its review of the eligibility of the common shares of the Company
(Symbol: RBM) for continued listing for a period of 30 days.
About TMX Group (TSX-X)
TMX Group's key subsidiaries operate cash and derivative markets for
multiple asset classes including equities, fixed income and energy. Toronto
Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange,
Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies
provide trading markets, clearing facilities, data products and other services
to the global financial community. TMX Group is headquartered in Toronto with
offices in Montreal, Calgary and Vancouver. For more information about TMX
Group, visit our website at www.tsx.com.
For further information:
For further information: Corporate Communications, TMX Group Inc., Toll
Free 1-888-873-8392, firstname.lastname@example.org